AnalystsChristopher LiuChristopher Liu's Stock Forecasts
AnalystsChristopher Liu
Sectors:
Industries:
Analyst Ranking
Top 36%
#1841 out of 5177 analysts
Average Return
+37.28%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Christopher Liu's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lyell Immunopharma IncLYEL | +85.19% | $12.83 | $23.76 | 2025-09-25 - 2026-01-16 | Strong Buy |
Relay Therapeutics IncRLAY | +78.36% | $4.39 | $7.83 | 2024-12-03 - 2025-12-03 | Buy |
Ideaya Biosciences IncIDYA | +65.71% | $21.64 | $35.86 | 2023-08-07 - 2024-08-07 | Buy |
Exelixis IncEXEL | +21.67% | $36.13 | $43.96 | 2025-10-20 - 2026-01-16 | Buy |
Christopher Liu Analyst Color
Get additional color on Christopher Liu's coverage of popular stocks
Christopher Liu's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 2 | Buy | $48.00 | +9.19% | Upgrades | 3 months ago |
Lyell Immunopharma IncLYEL | 1 | Strong Buy | $20.00 | -15.82% | Initiates Coverage On | 4 months ago |
Adagene IncADAG | 1 | Strong Buy | $9.00 | +359.18% | Initiates Coverage On | 4 months ago |
Genelux CorpGNLX | 1 | Strong Buy | $10.00 | +264.96% | Initiates Coverage On | 6 months ago |
Relay Therapeutics IncRLAY | 1 | Buy | $18.00 | N/A | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 2 | Hold | $27.00 | N/A | Downgrades | a year ago |
Nuvalent IncNUVL | 1 | Hold | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.